Submit your business proposal
日本語
About
Strategy
Team
Funds
Portfolio
News
Contact
Submit your business proposal
日本語
About
Strategy
Team
Funds
Portfolio
News
Contact
News
News type
Article
Event
Press release
Region
Japan
EU
Latest news
15th March 2024
Acticor Biotech completes a capital increase for a total gross amount of 8 million euros
Read more
26th January 2024
Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure
Read more
26th January 2024
PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions
Read more
4th January 2024
Sequana Medical granted US CPT® III reimbursement codes for alfapump® system
Read more
30th November 2023
Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure
Read more
30th November 2023
Acticor Biotech completes a capital increase for a total gross amount of approximately 2.6 million euros, via the issuance of 850,360 shares
Read more
29th November 2023
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
Read more
19th October 2023
Sequana Medical announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission
Read more
19th October 2023
Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome
Read more
1
2
3
Sign up
You are added to the list, thank you!